Zhiqiang An portrait
June 3, 2021

New IgM antibodies administered intranasally to fight COVID-19 more potent than commonly used ones

A nasal therapy, built upon on the application of a new engineered IgM antibody therapy for COVID-19, was more effective than commonly used IgG antibodies at neutralizing the COVID-19 virus in animal models, according to research recently published by The…


Researchers with UTHealth have found a possible explanation for why many cancer drugs that kill tumor cells in mouse models won’t work in human trials. (Photo by Getty Images)
April 1, 2021

Study finds why some cancer drugs may be ineffective

A possible explanation for why many cancer drugs that kill tumor cells in mouse models won’t work in human trials has been found by researchers with The University of Texas Health Science Center at Houston (UTHealth) School of Biomedical Informatics…


Zhiqiang An, PhD COVID-19 anitbody therapy
January 28, 2021

New antibody therapies found to potentially fight COVID-19

Researchers at McGovern Medical School and The University of Texas Medical Branch at Galveston (UTMB Health) have discovered a potential new antibody therapy for COVID-19. The study was published in Nature Communications. Antibodies are proteins that allow the body to fight viruses such as SARS-CoV-2,…


Pages